- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: CAY10572, NMS 1116354
PHA-767491 (CAY10572, NMS 1116354) HCl是一種有效的,ATP競爭性的,雙重Cdc7/CDK9抑制劑,無細胞試驗中IC50分別為10 nM和34 nM,比作用于CDK1/2和GSK3-β選擇性高20倍左右,比作用于MK2和CDK5選擇性高50倍,比作用于PLK1和CHK2選擇性高100倍。
PHA-767491 HCl Chemical Structure
CAS: 942425-68-5
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
human HeLa cells | Function assay | 5 μM | 24 h | Induction of apoptosis in human HeLa cells assessed as appearance of PARP at 5 uM after 24 hrs | 18469809 |
NHDF | Function assay | 5 μM | 16 h | Induction of cell cycle arrest in thymidine deficient NHDF assessed as DNA synthesis in S-phase at 5 uM after 16hrs FACS analysis in presence of serum | 18469809 |
human SF268 cells | Proliferation assay | 72 h | Antiproliferative activity against p53 deficient human SF268 cells after 72 hrs, IC50=0.86 μM | 18469809 | |
human HCT116 cells | Proliferation assay | 72 h | Antiproliferative activity against human HCT116 cells expressing p53 gene after 72 hrs by proliferative assay, IC50=0.97 μM | 18469809 | |
human HCT16 cells | Proliferation assay | 72 h | Antiproliferative activity against human HCT16 cells after 72 hrs by luciferase based assay, IC50=1 μM | 19115845 | |
human SW403 cells | Proliferation assay | 72 h | Antiproliferative activity against human SW403 cells after 72 hrs by luciferase based assay, IC50=1 μM | 19115845 | |
human A2780 cells | Proliferation assay | 72 h | Antiproliferative activity against human A2780 cells expressing p53 gene after 72 hrs by proliferative assay, IC50=1.07 μM | 18469809 | |
human SW48 cells | Proliferation assay | 72 h | Antiproliferative activity against human SW48 cells after 72 hrs by luciferase based assay, IC50=1.2 μM | 19115845 | |
human MCF7 cells | Proliferation assay | 72 h | Antiproliferative activity against human MCF7 cells after 72 hrs by luciferase based assay, IC50=1.3 μM | 19115845 | |
human U2OS cells | Proliferation assay | 72 h | Antiproliferative activity against human U2OS cells expressing p53 gene after 72 hrs by proliferative assay, IC50=1.49 μM | 18469809 | |
human COLO205 cells | Proliferation assay | 72 h | Antiproliferative activity against human COLO205 cells after 72 hrs by luciferase based assay, IC50=1.5 μM | 19115845 | |
human OVCAR8 cells | Proliferation assay | 72 h | Antiproliferative activity against p53 deficient human OVCAR8 cells after 72 hrs by proliferative assay, IC50=1.56 μM | 18469809 | |
human L363 cells | Proliferation assay | 72 h | Antiproliferative activity against human L363 cells after 72 hrs by luciferase based assay, IC50=1.6 μM | 19115845 | |
human NHDF cells | Proliferation assay | 72 h | Antiproliferative activity against human NHDF cells after 72 hrs by luciferase based assay, IC50=1.6 μM | 19115845 | |
human NCI-H929 cells | Proliferation assay | 72 h | Antiproliferative activity against human NCI-H929 cells after 72 hrs by luciferase based assay, IC50=1.8 μM | 19115845 | |
human SF539 cells | Proliferation assay | 72 h | Antiproliferative activity against human SF539 cells expressing p53 gene after 72 hrs by proliferative assay, IC50=2.34 μM | 18469809 | |
human SW480 cells | Proliferation assay | 72 h | Antiproliferative activity against p53 deficient human SW480 cells after 72 hrs by proliferative assay, IC50=2.67 μM | 18469809 | |
human Jurkat cells | Proliferation assay | 72 h | Antiproliferative activity against p53 deficient human Jurkat cells after 72 hrs by proliferative assay, IC50=3.2 μM | 18469809 | |
human HCT15 cells | Proliferation assay | 72 h | Antiproliferative activity against human HCT15 cells expressing p53 gene after 72 hrs by proliferative assay, IC50=3.81 μM | 18469809 | |
human OPM2 cells | Proliferation assay | 72 h | Antiproliferative activity against human OPM2 cells after 72 hrs by luciferase based assay, IC50=4.5 μM | 19115845 | |
human HT-29 cells | Proliferation assay | 72 h | Antiproliferative activity against human HT-29 cells after 72 hrs by luciferase based assay, IC50=5 μM | 19115845 | |
human K562 cells | Proliferation assay | 72 h | Antiproliferative activity against p53 deficient human K562 cells after 72 hrs, IC50=5.87 μM | 18469809 | |
human NCI60 cells | Proliferation assay | Antiproliferative activity against human NCI60 cells, IC50=3.1 μM | 18469809 | ||
U937 cells | Function assay | Inhibition of TNFalpha production in U937 cells, IC50=19 μM | 17480064 | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | PHA-767491 (CAY10572, NMS 1116354) HCl是一種有效的,ATP競爭性的,雙重Cdc7/CDK9抑制劑,無細胞試驗中IC50分別為10 nM和34 nM,比作用于CDK1/2和GSK3-β選擇性高20倍左右,比作用于MK2和CDK5選擇性高50倍,比作用于PLK1和CHK2選擇性高100倍。 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
特性 | PHA-767491是第一個通過控制 DNA 復制起始而不是延伸階段而影響機制的抑制劑。 | |||||||||||
靶點 |
|
分子量 | 249.7 | 分子式 | C12H11N3O.HCl |
CAS號 | 942425-68-5 | SDF | Download PHA-767491 HCl SDF |
Smiles | C1CNC(=O)C2=C1NC(=C2)C3=CC=NC=C3.Cl | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 24 mg/mL ( (96.11 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Water : Insoluble Ethanol : Insoluble |
摩爾濃度計算器 |
體內(nèi)溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內(nèi)配方計算器 |
動物體內(nèi)配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項